✦ LIBER ✦

The usefulness of ciclosporin (Sandimmun) in the treatment ofBehcet's syndrome: Preliminary results of an open study

✍ Scribed by Pacor, M.L.; Bambara, L.M.; Peroli, P.; Biasi, D.; Urbani, G.; Cortina, P.; Nicolis, F.; Lombardo, G.; Lunardi, C.

Book ID: 122897763
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 51 KB
Volume: 5
Category: Article
ISSN: 0896-8411
DOI: 10.1016/0896-8411(92)90063-V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary Results of an Open Label Stu

Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression

✍ Maria Katsamanis Karavidas; Paul M. Lehrer; Evgeny Vaschillo; Bronya Vaschillo; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 334 KB

High-dose intravenous immunoglobulin in

High-dose intravenous immunoglobulin in the treatment of Guillain-Barré syndrome: a preliminary open study

✍ Matthew C. Jackson; Richard B. Godwin-Austen; Alan M. Whiteley 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 274 KB

Duloxetine in the treatment of irritable

Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study

✍ Brian P. Brennan; Kate V. Fogarty; Jacqueline L. Roberts; Karina A. Reynolds; Ha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). ## Methods We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS without concurrent major depressive disorder. The primary outcome measure was average abdominal

P.3.c.003 An open label study of the use

P.3.c.003 An open label study of the use of aripiprazole in the treatment of chronic PTSD: preliminary findings

✍ M. Hopwood; J. Wardell; P. Chen; K. Wallace; I. Krivonos 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Gabapentin has little or no effect in th

Gabapentin has little or no effect in the treatment of burning mouth syndrome – results of an open-label pilot study

✍ S. M. Heckmann; J. G. Heckmann; A. Ungethüm; P. Hujoel; T. Hummel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Extracorporeal photopheresis for the tre

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: Results of an open-label pilot study

✍ Maria T. Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o